{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:42:54Z","timestamp":1778154174154,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008360","name":"Hamilton Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jcjd.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T22:13:25Z","timestamp":1702332805000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of COVID-19 Lockdown on Occurrence of Acute Complications of Type 1 and Type 2 Diabetes and Overall Glycemic Management"],"prefix":"10.1016","volume":"48","author":[{"given":"Richa","family":"Parihar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simrit","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-3617","authenticated-orcid":false,"given":"Zubin","family":"Punthakee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hertzel","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoela","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Pigeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2023.12.001_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jcjd.2023.12.001_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.dsx.2020.04.049","article-title":"COVID-19 and diabetes mellitus: An unholy interaction of two pandemics","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jcjd.2023.12.001_bib3","first-page":"6","article-title":"COVID-19 presenting with diabetic ketoacidosis: A case series","volume":"7","author":"Gorthi","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.jcjd.2023.12.001_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EC-20-0567","article-title":"Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes","volume":"10","author":"Kempegowda","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jcjd.2023.12.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108348","article-title":"Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes","volume":"166","author":"Fern\u00e1ndez","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2023.12.001_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.pcd.2021.01.003","article-title":"Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people","volume":"15","author":"Karatas","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.jcjd.2023.12.001_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.669302","article-title":"The impact of COVID-19 pandemic lockdown on the incidence of new-onset type 1 diabetes and ketoacidosis among Saudi children","volume":"12","author":"Alaqeel","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2023.12.001_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/pedi.13296","article-title":"Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in Israel","volume":"23","author":"Goldman","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcjd.2023.12.001_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.eprac.2022.02.005","article-title":"Increase in the number of pediatric new-onset diabetes and diabetic ketoacidosis cases during the COVID-19 pandemic","volume":"28","author":"Chambers","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jcjd.2023.12.001_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13098-021-00705-9","article-title":"Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: A systematic review","volume":"13","author":"Eberle","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jcjd.2023.12.001_bib11","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa149","article-title":"Impact of COVID-19 lockdown on glycemic control in adults with type 1 diabetes mellitus","volume":"4","author":"Pla","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jcjd.2023.12.001_bib12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dsx.2020.07.016","article-title":"Impact of lockdown in COVID 19 on glycemic control in patients with type 1 diabetes mellitus","volume":"14","author":"Verma","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jcjd.2023.12.001_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu12082327","article-title":"COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus","volume":"12","author":"Ruiz-Roso","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jcjd.2023.12.001_bib14","article-title":"COVID-19 and type 1 diabetes: Concerns and challenges","volume":"91","author":"Trevisani","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.jcjd.2023.12.001_bib15","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00125-017-4365-5","article-title":"Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: The TEDDY study","volume":"60","author":"L\u00f6nnrot","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2023.12.001_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcjd.2021.04.006","article-title":"Sodium-glucose cotransporter-2 inhibitors and risk of diabetic ketoacidosis among adults with type 2 diabetes: A systematic review and meta-analysis","volume":"46","author":"Colacci","year":"2022","journal-title":"Can J Diabetes"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123007207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267123007207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:40:01Z","timestamp":1761493201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267123007207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1499267123007207"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.12.001","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of COVID-19 Lockdown on Occurrence of Acute Complications of Type 1 and Type 2 Diabetes and Overall Glycemic Management","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}